Companies: 10,795·Total market cap: $144.5T
Adlai Nortye Ltd.

Adlai Nortye Ltd.

ANLNASDAQHealthcare● Active
$10.23
+$0.28(+2.81%)
Market Cap$543008400
P/E Ratio—
52W High$17.25
52W Low$0.879
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Adlai Nortye Ltd. (ANL) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001944552 · ANL · NASDAQ · as of Jun 9, 2026

Filing snapshot

90
Total Filings
3
Latest Form
2026-06-01
Most Recent
2023
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001944552 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-04-10
Fiscal Year End
Apr 10, 2026
Accession No.
0001213900-26-042520
Primary Document
ea0282593-20f_adlai.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001944552 · Accession 0001213900-26-042520

Latest Key Filings

6-KQuarterly Report
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-16
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2026-06-01
View
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2026-05-28
View
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2026-05-21
View
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2026-05-20
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-14
View
3/AInitial Statement of Beneficial Ownership (Amended)
PRIMARY DOCUMENT
2026-05-14
View
3/AInitial Statement of Beneficial Ownership (Amended)
PRIMARY DOCUMENT
2026-05-08
View
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2026-05-08
View
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2026-04-29
View
EFFECTEFFECT
EFFECT
2026-04-28
View
CORRESPCORRESP
CORRESP
2026-04-24
View
F-3/AF-3/A
AMENDMENT NO. 2 TO FORM F-3
2026-04-24
View
F-3/AF-3/A
AMENDMENT NO. 1 TO FORM F-3
2026-04-23
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-16
View
Showing 1–15 of 89 filingsForm 4 / 144 hidden· 90 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001944552  |  Exchange: NASDAQ · Healthcare

Adlai Nortye Ltd. (NASDAQ: ANL) has submitted 90 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2023. As a Healthcare sector company with CIK 0001944552, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Adlai Nortye Ltd.'s most comprehensive regulatory disclosure. The most recent Adlai Nortye Ltd. 10-K was filed on 2026-04-10 for fiscal year ending 2026. Historical ANL 10-K annual reports are available from 2022 through 2026.

Investors researching Adlai Nortye Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
THAR SEC Filings →APLM SEC Filings →BLRX SEC Filings →ADAP SEC Filings →LPCN SEC Filings →OSRH SEC Filings →AIMD SEC Filings →ICU SEC Filings →
→ ANL Financials→ ANL Earnings→ ANL Insider Trades

Frequently Asked Questions

ANL SEC Filings · 8 questions

Adlai Nortye Ltd. (ANL) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 90 filings and access original documents at no cost. Adlai Nortye Ltd.'s CIK is 0001944552.

ANL SEC filingsAdlai Nortye Ltd. SEC documentsfind ANL 10-K